Back to results
CompletedPhase 2

A Study of Aleglitazar in Patients With Type 2 Diabetes

NCT00388518

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Phoenix, Arizona, United States

+54 additional locations

View on ClinicalTrials.gov